The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors that is predominantly expressed in adipose tissue, adrenal gland and spleen. PPAR-gamma has been demonstrated to regulate adipocyte differentiation and glucose homeostasis in response to several structurally distinct compounds, including thiazolidinediones and fibrates. Naturally occurring compounds such as fatty acids and the prostaglandin D2 metabolite 15-deoxy-delta prostaglandin J2 (15d-PGJ2) bind to PPAR-gamma and stimulate transcription of target genes. Prostaglandin D2 metabolites have not yet been identified in adipose tissue, but are major products of arachidonic-acid metabolism in macrophages, raising the possibility that they might serve as endogenous PPAR-gamma ligands in this cell type. Here we show that PPAR-gamma is markedly upregulated in activated macrophages and inhibits the expression of the inducible nitric oxide synthase, gelatinase B and scavenger receptor A genes in response to 15d-PGJ2 and synthetic PPAR-gamma ligands. PPAR-gamma inhibits gene expression in part by antagonizing the activities of the transcription factors AP-1, STAT and NF-kappaB. These observations suggest that PPAR-gamma and locally produced prostaglandin D2 metabolites are involved in the regulation of inflammatory responses, and raise the possibility that synthetic PPAR-gamma ligands may be of therapeutic value in human diseases such as atherosclerosis and rheumatoid arthritis in which activated macrophages exert pathogenic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In microglia and macrophages, PPAR␥ activation inhibits proinflammatory gene expression (Jiang et al., 1998;Ricote et al., 1998).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Ricote et al., 1998
In the citing paper
“Moreover, inhibiting nuclear factor B (NFB) decreases expression of inflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor ␣ (TNF␣) or IL-6 (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“PPAR␥ is well established for its anti-inflammatory effects in attenuating the production of pro-inflammatory mediators (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Items 501–600 of 1,039
Heming, M., Gran, S., Jauch, S.-L., Fischer-Riepe, L., Russo, A., Klotz, L., Hermann, S., Schäfers, M., Roth, J., & Barczyk-Kahlert, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00893 · Cited by 155
PPARγ in immunity and inflammation: cell types and diseases
Széles, L., Törőcsik, D., & Nagy, L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.005 · Cited by 196
Rivier, M., Safonova, I., Lebrun, P., Michel, S., Griffiths, C. E. M., & Ailhaud, G. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00439.x · Cited by 162
Wang, C., Fu, M., D'Amico, M., Albanese, C., Zhou, J.-N., Brownlee, M., Lisanti, M. P., Chatterjee, V. K. K., Lazar, M. A., & Pestell, R. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3057-3070.2001 · Cited by 165
Lundin, A., Bok, C. M., Aronsson, L., Björkholm, B., Gustafsson, J.-Å., Pott, S., Arulampalam, V., Hibberd, M., Rafter, J., & Pettersson, S. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01108.x · Cited by 153
Norata, G. D., Tibolla, G., Seccomandi, P. M., Poletti, A., & Catapano, A. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1664 · Cited by 163
Hontecillas, R., & Bassaganya-Riera, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2940 · Cited by 166
Bencze, M., Negroni, E., Vallese, D., Yacoub-Youssef, H., Chaouch, S., Wolff, A., Aamiri, A., Di Santo, J. P., Chazaud, B., Butler-Browne, G., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.189 · Cited by 152
Ricote, M., Valledor, A. F., & Glass, C. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000103951.67680.b1 · Cited by 162
Self-citationMacdougall, C. E., Wood, E. G., Loschko, J., Scagliotti, V., Cassidy, F. C., Robinson, M. E., Feldhahn, N., Castellano, L., Voisin, M.-B., Marelli-Berg, F., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.007 · Cited by 154
Hagihara, M., Kuroki, Y., Ariyoshi, T., Higashi, S., Fukuda, K., Yamashita, R., Matsumoto, A., Mori, T., Mimura, K., Yamaguchi, N., et al. (2020) · iScience · doi:10.1016/j.isci.2019.100772 · Cited by 162
Hammad, H., de Heer, H. J., Soullié, T., Angeli, V., Trottein, F., Hoogsteden, H. C., & Lambrecht, B. N. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63116-1 · Cited by 161
The nuclear receptor PPARγ individually responds to serotonin‐ and fatty acid‐metabolites
Waku, T., Shiraki, T., Oyama, T., Maebara, K., Nakamori, R., & Morikawa, K. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.197 · Cited by 158
Emerging Principles of Gene Expression Programs and Their Regulation
Pope, S. D., & Medzhitov, R. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.017 · Cited by 156
Structural Insight into PPARγ Activation Through Covalent Modification with Endogenous Fatty Acids
Waku, T., Shiraki, T., Oyama, T., Fujimoto, Y., Maebara, K., Kamiya, N., Jingami, H., & Morikawa, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.039 · Cited by 178
Dello Russo, C., Gavrilyuk, V., Weinberg, G., Almeida, A., Bolanos, J. P., Palmer, J., Pelligrino, D., Galea, E., & Feinstein, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208132200 · Cited by 164
MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages
Huang, C., Liu, X.-J., QunZhou, Xie, J., Ma, T.-T., Meng, X.-M., & Li, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.009 · Cited by 160
Transcriptional Repression of pref-1by Glucocorticoids Promotes 3T3-L1 Adipocyte Differentiation
Smas, C. M., Chen, L., Zhao, L., Latasa, M.-J., & Sul, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12632 · Cited by 154
Faveeuw, C., Fougeray, S., Angeli, V., Fontaine, J., Chinetti, G., Gosset, P., Delerive, P., Maliszewski, C., Capron, M., Staels, B., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02319-x · Cited by 158
Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins
Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J., & Uchida, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303690200 · Cited by 161
Wung, B., Hsu, M. C., Wu, C., & Hsieh, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.052 · Cited by 167
van de Ree, M. A., Huisman, M. V., Princen, H. M. G., Meinders, A. E., & Kluft, C. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00316-7 · Cited by 159
Prostaglandin D2 and sleep regulation
Urade, Y., & Hayaishi, O. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00163-5 · Cited by 162
Lipopolysaccharide increases resistin gene expression in vivo and in vitro
Lu, S.-C., Shieh, W.-Y., Chen, C.-Y., Hsu, S.-C., & Chen, H.-L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03450-6 · Cited by 156
Gervois, P., Vu-Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J.-C., Kooistra, T., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102839200 · Cited by 153
M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment
Bi, Y., Chen, J., Hu, F., Liu, J., Li, M., & Zhao, L. (2019) · Neural Plasticity · doi:10.1155/2019/6724903 · Cited by 150
Shen, B., Zhao, C., Wang, Y., Peng, Y., Cheng, J., Li, Z., Wu, L., Jin, M., & Feng, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14293 · Cited by 163
Oxidative Stress and Transcriptional Regulation in Alzheimer Disease
Shi, Q., & Gibson, G. E. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815721c3 · Cited by 157
Komar, C. M., Braissant, O., Wahli, W., & Curry, T. E. (2001) · Endocrinology · doi:10.1210/en.142.11.4831 · Cited by 155
Vasa Vasorum in Atherosclerosis and Clinical Significance
Xu, J., Lu, X., & Shi, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511574 · Cited by 171
Gallardo-Soler, A., Gómez-Nieto, C., Campo, M. L., Marathe, C., Tontonoz, P., Castrillo, A., & Corraliza, I. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0525 · Cited by 151
Sauerbeck, A., Gao, J., Readnower, R., Liu, M., Pauly, J. R., Bing, G., & Sullivan, P. G. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.003 · Cited by 156
Majer, O., Bourgeois, C., Zwolanek, F., Lassnig, C., Kerjaschki, D., Mack, M., Müller, M., & Kuchler, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002811 · Cited by 156
Psoriasis and comorbidities: links and risks
Chiu, M. W., & Ni, C. S. (2014) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s44843 · Cited by 180
Control of Vascular Cell Proliferation and Migration by PPAR-γ
Hsueh, W. A., Jackson, S., & Law, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.392 · Cited by 158
Selenium attenuates pro‐inflammatory gene expression in macrophages
Vunta, H., Belda, B. J., Arner, R. J., Channa Reddy, C., Vanden Heuvel, J. P., & Sandeep Prabhu, K. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700346 · Cited by 157
Macrophages: An elusive yet emerging therapeutic target of atherosclerosis
Tiwari, R. L., Singh, V., & Barthwal, M. K. (2008) · Medicinal Research Reviews · doi:10.1002/med.20118 · Cited by 153
Jahoor, A., Patel, R., Bryan, A., Do, C., Krier, J., Watters, C., Wahli, W., Li, G., Williams, S. C., & Rumbaugh, K. P. (2008) · Journal of Bacteriology · doi:10.1128/jb.01444-07 · Cited by 172
Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs)
Sporn, M. B., Suh, N., & Mangelsdorf, D. J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02100-1 · Cited by 159
Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway
Chen, Y., Morrow, J. D., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10863 · Cited by 156
Carbon Monoxide Orchestrates a Protective Response through PPARγ
Bilban, M., Bach, F. H., Otterbein, S. L., Ifedigbo, E., d’Avila, J. C., Esterbauer, H., Chin, B. Y., Usheva, A., Robson, S. C., Wagner, O. F., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.012 · Cited by 166
Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2on bleomycin-induced lung injury
Genovese, T., Cuzzocrea, S., Di Paola, R., Mazzon, E., Mastruzzo, C., Catalano, P., Sortino, M., Crimi, N., Caputi, A. P., Thiemermann, C., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00049704 · Cited by 154
Storer, P. D., Xu, J., Chavis, J., & Drew, P. D. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.12.015 · Cited by 154
Kulke, M. H., Demetri, G. D., Sharpless, N. E., Ryan, D. P., Shivdasani, R., Clark, J. S., Spiegelman, B. M., Kim, H., Mayer, R. J., & Fuchs, C. S. (2002) · The Cancer Journal · doi:10.1097/00130404-200209000-00010 · Cited by 150
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-?? IS A NEW THERAPEUTIC TARGET IN SEPSIS AND INFLAMMATION
Zingarelli, B., & Cook, J. A. (2005) · Shock · doi:10.1097/01.shk.0000160521.91363.88 · Cited by 155
Chemokines and atherosclerosis
Terkeltaub, R. A., Boisvert, W. A., & Curtiss, L. K. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00003 · Cited by 162
Lipoproteins, macrophage function, and atherosclerosis: Beyond the foam cell?
Rader, D. J., & Puré, E. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.005 · Cited by 167
Diabetes Mellitus and Macrovascular Disease: Mechanisms and Mediators
Boyle, P. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.003 · Cited by 173
Immunometabolic crosstalk during bacterial infection
Rosenberg, G., Riquelme, S. A., Prince, A. S., & Avraham, R. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01080-5 · Cited by 155
PPAR: a therapeutic target in Parkinson’s disease
Chaturvedi, R. K., & Beal, M. F. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05388.x · Cited by 146
Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity
Orliaguet, L., Dalmas, E., Drareni, K., Venteclef, N., & Alzaid, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00062 · Cited by 144
Kyrkanides, S., Moore, A. H., Olschowka, J. A., Daeschner, J., Williams, J. P., Hansen, J. T., & O’Banion, M. K. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00353-4 · Cited by 162
PPARγ‐dependent regulation of human macrophages in phagocytosis of apoptotic cells
Majai, G., Sarang, Z., Csomós, K., Zahuczky, G., & Fésüs, L. (2007) · European Journal of Immunology · doi:10.1002/eji.200636398 · Cited by 146
Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 157
Trifilieff, A., Bench, A., Hanley, M., Bayley, D., Campbell, E., & Whittaker, P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705232 · Cited by 148
Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
Moore, A. H., & O’Banion, M. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00162-x · Cited by 171
Padilla, J., Kaur, K., Cao, H., Smith, T. J., & Phipps, R. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6941 · Cited by 161
Heneka, M. T., L. Feinstein, D., Galea, E., Gleichmann, M., Wüllner, U., & Klockgether, T. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00192-7 · Cited by 150
Kim, E. H., & Surh, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.030 · Cited by 166
Liao, W., Nguyen, M. T. A., Yoshizaki, T., Favelyukis, S., Patsouris, D., Imamura, T., Verma, I. M., & Olefsky, J. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00695.2006 · Cited by 142
Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential
Gudoityte, E., Arandarčikaitė, O., Mažeikienė, I., Bendokas, V., & Liobikas, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094599 · Cited by 158
PPAR /RXR Heterodimers Control Human Trophoblast Invasion
Couturier‐Tarrade, A., Schoonjans, K., Pavan, L., Auwerx, J. H., Rochette‐Egly, C., Evain‐Brion, D., & Fournier, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.5017 · Cited by 173
Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway
Robbesyn, F., Salvayre, R., & Negre-Salvayre, A. (2004) · Free Radical Research · doi:10.1080/10715760410001665244 · Cited by 143
Hubmayr, R. D., Burchardi, H., Elliot, M., Fessler, H., Georgopoulos, D., Jubran, A., Limper, A., Pesenti, A., Rubenfeld, G., Stewart, T., et al. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1514-0 · Cited by 163
Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies
Takada, I., Kouzmenko, A. P., & Kato, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902915310 · Cited by 145
PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolism
Nelson, V. L., Nguyen, H. C. B., Garcìa-Cañaveras, J. C., Briggs, E. R., Ho, W. Y., DiSpirito, J. R., Marinis, J. M., Hill, D. A., & Lazar, M. A. (2018) · Genes & Development · doi:10.1101/gad.312355.118 · Cited by 141
The many faces of PPARγ: Anti-inflammatory by any means?
Szántó, A., & Nagy, L. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.015 · Cited by 162
Microbial Metabolites Determine Host Health and the Status of Some Diseases
Sittipo, P., Shim, J.-W., & Lee, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215296 · Cited by 136
Peroxisome Proliferator-activated Receptor-γ as a Regulator of Lung Inflammation and Repair
Standiford, T. J., Keshamouni, V. G., & Reddy, R. C. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200501-010ac · Cited by 147
Iglarz, M., Touyz, R. M., Viel, E. C., Paradis, P., Amiri, F., Diep, Q. N., & Schiffrin, E. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000083511.91817.b1 · Cited by 146
Hisatake, J., Ikezoe, T., Carey, M., Holden, S. A., Tomoyasu, S., & Koeffler, H. P. (2000) · PubMed · Cited by 167
Aljada, A., Garg, R., Ghanim, H., Mohanty, P., Hamouda, W., Assian, E., & Dandona, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7564 · Cited by 133
Fibrates, dyslipoproteinaemia and cardiovascular disease
Watts, G. F., & Dimmitt, S. B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00011 · Cited by 147
Baek, S. J., Kim, J.-S., Nixon, J. B., DiAugustine, R. P., & Eling, T. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305295200 · Cited by 145
Yoon, Y.-S., Kim, S.-Y., Kim, M.-J., Lim, J.-H., Cho, M.-S., & Kang, J. L. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.130 · Cited by 145
“Activation of PPARg has been linked to glucose homeostasis,(10) cellular differentiation,(11) apoptosis,(12) and antiinflammatory responses.(13) Within the lung, PPARg is expressed by the epithelium, smooth muscle cells, fibroblasts, endothelium, macrophages, eosinophils, and dendritic cells.”
BackgroundDownregulation of Endothelin-1 by Farnesoid X Receptor in Vascular Endothelial Cells
He, F., Li, J., Mu, Y., Kuruba, R., Ma, Z., Wilson, A., Alber, S., Jiang, Y., Stevens, T., Watkins, S., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000200400.55539.85 · Cited by 146
Insulin‐independent glucose transport regulates insulin sensitivity
Ebeling, P., Koistinen, H. A., & Koivisto, V. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01149-1 · Cited by 155
Takada, I., Suzawa, M., Matsumoto, K., & Kato, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.034 · Cited by 154
Effects of peroxisome proliferators on the thymus and spleen of mice
Yang, Q., Xie, Y., & Depierre, J. W. (2008) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01367.x · Cited by 143
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 160
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Xu, J.-Y., & Chen, C. (2015) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 135
Reka, A. K., Kurapati, H., Narala, V. R., Bommer, G., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0570 · Cited by 136
Musiek, E. S., Brooks, J. D., Joo, M., Brunoldi, E., Porta, A., Zanoni, G., Vidari, G., Blackwell, T. S., Montine, T. J., Milne, G. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803625200 · Cited by 139
Kielian, T., & Drew, P. D. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10501 · Cited by 140
Altered PPARγ expression and activation after transient focal ischemia in rats
Victor, N. A., Wanderi, E. W., Gamboa, J., Zhao, X., Aronowski, J., Deininger, K., Lust, W. D., Landreth, G. E., & Sundararajan, S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05037.x · Cited by 142
Honda, K., Marquillies, P., Capron, M., & Dombrowicz, D. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.036 · Cited by 157
Colonic anti-inflammatory mechanisms of conjugated linoleic acid
Bassaganya-Riera, J., Hontecillas, R., & Beitz, D. C. (2002) · Clinical Nutrition · doi:10.1054/clnu.2002.0594 · Cited by 162
Lipopolysaccharide Induces Macrophage Migration via Prostaglandin D2 and Prostaglandin E2
Tajima, T., Murata, T., Aritake, K., Urade, Y., Hirai, H., Nakamura, M., Ozaki, H., & Hori, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137992 · Cited by 161
Sepsis-Induced Immunosuppression From Bad to Worse
Reddy, R. C., Chen, G. H., Tekchandani, P. K., & Standiford, T. J. (2001) · Immunologic Research · doi:10.1385/ir:24:3:273 · Cited by 153
Mehta, R. G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.418 · Cited by 147
ROLE OF MACROPHAGES IN COMPLICATIONS OF TYPE 2 DIABETES
Tesch, G. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04729.x · Cited by 139
Xu, J., Storer, P. D., Chavis, J. A., Racke, M. K., & Drew, P. D. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20518 · Cited by 142
Masamune, A., Kikuta, K., Satoh, M., Sakai, Y., Satoh, A., & Shimosegawa, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107582200 · Cited by 138
Oliver, E., McGillicuddy, F., Phillips, C., Toomey, S., & Roche, H. M. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110000042 · Cited by 136
Goodman, S. B., Gibon, E., Pajarinen, J., Lin, T., Keeney, M., Ren, P., Nich, C., Yao, Z., Egashira, K., Yang, F., et al. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0962 · Cited by 149
Arachidonic acid cascade in endothelial pathobiology
Bogatcheva, N. V., Sergeeva, M. G., Dudek, S. M., & Verin, A. D. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.01.007 · Cited by 141
Neuroinflammation in Alzheimer’s Disease
Reinisch, V. M., Krause, D., & Müller, N. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_9 · Cited by 142
13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells
Altmann, R., Hausmann, M., Spöttl, T., Gruber, M. A., Bull, A. W., Menzel, K., Vogl, D., Herfarth, H. H., Schölmerich, J., Falk, W., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.027 · Cited by 146
Collagen Membrane and Immune Response in Guided Bone Regeneration: Recent Progress and Perspectives
Chu, C., Deng, J., Sun, X., Qu, Y., & Man, Y. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0463 · Cited by 138
15-Deoxy-Δ12,14-prostaglandin J2: An Electrophilic Trigger of Cellular Responses
Uchida, K., & Shibata, T. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700177j · Cited by 139
Metadata
- Authors
- Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K.
- Affiliations
- United States Department of Veterans Affairs (US)
- Veterans Health Administration (US)
- University of California San Diego (US)
- Corresponding author
- Glass, Christopher K.
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6662
- Pages
- 79-82
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1633340712
- Cited by
- 3,525
- References
- 27
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 34 · 2023: 44 · 2022: 59 · 2021: 84 · 2020: 73 · 2019: 65 · 2018: 89 · 2017: 82 · 2016: 86 · 2015: 95 · 2014: 113 · 2013: 106 · 2012: 137
- FWCI
- 53.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- PPARγ, macrophage activation, prostaglandin D2 metabolites, inducible nitric oxide synthase, MMP-9, scavenger receptor A, AP-1, STAT, NF-κB, transcriptional regulation, inflammation, atherosclerosis, rheumatoid arthritis, PPARγ ligands
- MeSH terms
- Bone Marrow Cells, Gene Expression Regulation, HeLa Cells, Humans, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Transcription Factors, Tumor Cells, Cultured, Prostaglandin D2, Collagenases, Macrophages, Peritoneal, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Nitric Oxide Synthase, Matrix Metalloproteinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.